The Molecular Pathology of Non-Malignant Haematological Disease

• by A. D. Blann, R. G. Dunn

• May 22, 2026

Assessment of Clinical Complications and Treatment Approaches in Non-Transfusion-Dependent α- and β-Thalassemia Patients Compared to Matched Controls: A Retrospective Analysis Utilizing Administrative Claims Data in the United States

• by Arielle L. Langer, Amey Rane, Keely S. Gilroy, Jing Zhao, Louise Lombard, Carolyn R. Lew, Sujit Sheth

• March 30, 2026

The patients demanding unvaccinated blood transfusions

• by Torie Bosch

• May 27, 2026

Toni Choueiri, MD discusses a novel HIF-2alpha inhibitor called casdatifan

Results show it was well-tolerated and showed promising early clinical activity in heavily pretreated patients with clear cell renal cell carcinoma. 

• February 26, 2025

• 1 min